» Authors » Michael Cannon

Michael Cannon

Explore the profile of Michael Cannon including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 18
Citations 416
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Humphrey M, Russell L, Danila M, Fink H, Guyatt G, Cannon M, et al.
Arthritis Care Res (Hoboken) . 2023 Oct; 75(12):2405-2419. PMID: 37884467
Objective: The objective is to update recommendations for prevention and treatment of glucocorticoid-induced osteoporosis (GIOP) for patients with rheumatic or nonrheumatic conditions receiving >3 months treatment with glucocorticoids (GCs) ≥2.5...
2.
Humphrey M, Russell L, Danila M, Fink H, Guyatt G, Cannon M, et al.
Arthritis Rheumatol . 2023 Oct; 75(12):2088-2102. PMID: 37845798
Objective: The objective is to update recommendations for prevention and treatment of glucocorticoid-induced osteoporosis (GIOP) for patients with rheumatic or nonrheumatic conditions receiving >3 months treatment with glucocorticoids (GCs) ≥2.5...
3.
Teachout E, Rosenthal J, Smith E, Gwao G, Kawiche P, Assey V, et al.
Food Nutr Bull . 2023 Apr; 44(2):126-135. PMID: 37016819
Introduction: Tanzania aimed to reduce micronutrient deficiencies and neural tube defects by introducing mandatory fortification of large-scale packaged wheat and maize flour but not for small- and medium-scale mills. Objectives:...
4.
Shams C, Cannon M, Bortman J, Hakim S
ACG Case Rep J . 2018 Sep; 5:e60. PMID: 30214909
A biliary enteric fistula (BEF) is a rare, abnormal communication between any segment of the biliary tree with any portion of the small or large intestine. BEF is more frequently...
5.
Cannon M, Khambe D, Klukowska M, Ramsey D, Miner M, Huggins T, et al.
J Clin Dent . 2018 May; 29(1):1-12. PMID: 29758151
Objectives: The clinical effects of stannous fluoride (SnF2) dentifrice in reducing symptoms of gingivitis and reducing the virulence of subgingival plaque through suppression of activation of gene expression in toll...
6.
Mehta J, Maloney E, Srinivasan S, Seitz P, Cannon M
Cureus . 2017 Nov; 9(9):e1702. PMID: 29159009
Nivolumab is a programmed cell death receptor (PD-1) inhibitor therapy for aggressive cancers; however, it poses a risk of immune-related adverse side effects. We present a 73-year-old male with renal...
7.
Buckley L, Guyatt G, Fink H, Cannon M, Grossman J, Hansen K, et al.
Arthritis Care Res (Hoboken) . 2017 Jun; 69(8):1095-1110. PMID: 28585410
Objective: To develop recommendations for prevention and treatment of glucocorticoid-induced osteoporosis (GIOP). Methods: We conducted a systematic review to synthesize the evidence for the benefits and harms of GIOP prevention...
8.
Buckley L, Guyatt G, Fink H, Cannon M, Grossman J, Hansen K, et al.
Arthritis Rheumatol . 2017 Jun; 69(8):1521-1537. PMID: 28585373
Objective: To develop recommendations for prevention and treatment of glucocorticoid-induced osteoporosis (GIOP). Methods: We conducted a systematic review to synthesize the evidence for the benefits and harms of GIOP prevention...
9.
Rosenthal J, Largaespada N, Bailey L, Cannon M, Alverson C, Ortiz D, et al.
J Nutr . 2017 Apr; 147(6):1183-1193. PMID: 28404832
Folate deficiency, vitamin B-12 deficiency, and anemia can have adverse effects on birth outcomes. Also, low vitamin B-12 reduces the formation of metabolically active folate. We sought to establish the...
10.
Klukowska M, Goyal C, Khambe D, Cannon M, Miner M, Gurich N, et al.
Am J Dent . 2015 Dec; 28(5):273-84. PMID: 26714345
Purpose: To compare the clinical, microbiological and metabonomic profiles of subjects with high and low levels of chronic gingival bleeding during a controlled oral hygiene regimen intervention including sequential phases...